Nalaganje...
Bevacizumab and intraocular tumors: an intriguing paradox
PURPOSE: Bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor-A (VEGF-A), was originally developed as an anti-tumor treatment. In ocular oncology, it is being used to treat macular edema due to radiation retinopathy, but it may also be useful for the treatment of primar...
Shranjeno v:
Main Authors: | , , , , , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
Molecular Vision
2012
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472924/ https://ncbi.nlm.nih.gov/pubmed/23077404 |
Oznake: |
Označite
Brez oznak, prvi označite!
|